{"id":40724,"date":"2021-06-01T07:42:32","date_gmt":"2021-06-01T07:42:32","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=40724"},"modified":"2021-06-01T08:43:42","modified_gmt":"2021-06-01T08:43:42","slug":"28th-conference-on-retroviruses-and-opportunistic-infections-croi-2021-virtual","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/40724","title":{"rendered":"28th Conference on Retroviruses and Opportunistic Infections (CROI 2021) virtual"},"content":{"rendered":"<div>\n<p class=\"HTBsubhead2articletitle\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-40209\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/03\/CROI-2021-logo-213x300.png\" alt=\"\" width=\"213\" height=\"300\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/03\/CROI-2021-logo-213x300.png 213w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2021\/03\/CROI-2021-logo.png 371w\" sizes=\"auto, (max-width: 213px) 100vw, 213px\" \/>6\u201310 March 2021<\/strong><\/p>\n<h2>Introduction<\/h2>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><strong>These reports concludes our coverage from the CROI 2021 virtual conference.<\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\">All conference materials are now available as open access documents on the CROI website, including webcasts.<br \/>\n<a href=\"https:\/\/www.croiconference.org\"><span lang=\"EN-US\">https:\/\/www.croiconference.org<\/span><\/a><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Articles in this issue of HTB are:<\/span><\/p>\n<\/div>\n<div>\n<ul>\n<li class=\"HTBBODYindent\"><a href=\"https:\/\/i-base.info\/htb\/40713\"><span lang=\"EN-US\">No differences in outcomes among women with and without HIV with high-risk pregnancies and COVID-19<\/span><\/a><\/li>\n<li class=\"HTBBODYindent\"><a href=\"https:\/\/i-base.info\/htb\/40691\">Dolutegravir-based regimens safe and effective in pregnancy and postpartum<\/a><\/li>\n<li class=\"HTBBODYindent\"><a href=\"https:\/\/i-base.info\/htb\/40697\">Dolutegravir superior to standard of care in children and adolescents: results from the ODYSSEY trial<\/a><\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>6\u201310 March 2021 Introduction These reports concludes our coverage from the CROI 2021 virtual conference. All conference materials are now available as open access documents on the CROI website, including webcasts. https:\/\/www.croiconference.org Articles in this issue of HTB are: No &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[307],"class_list":["post-40724","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-croi-2021-virtual"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/40724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=40724"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/40724\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=40724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=40724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=40724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}